Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis-Reference-Cited by-同舟云学术

Long-term effect of antiviral therapy on disease course after decompensation in patients with hepatitis B virus-related cirrhosis

Published:2015-03-18 Issue:6 Volume:61 Page:1809-1820
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Jang Jeong Won¹²,Choi Jong Young¹²,Kim Young Seok³²,Woo Hyun Young⁴²,Choi Sung Kyu⁵²,Lee Chang Hyeong⁶²,Kim Tae Yeob⁷²,Sohn Joo Hyun⁷²,Tak Won Young⁸²,Han Kwang-Hyub⁹²

Affiliation:

1. Department of Internal Medicine; The Catholic University of Korea, College of Medicine; Seoul Korea

2. Liver Cirrhosis Clinical Research Center; Seoul Korea

3. Department of Internal Medicine; Soonchunhyang University College of Medicine; Bucheon Korea

4. Department of Internal Medicine; Pusan National University Hospital; Busan Korea

5. Department of Internal Medicine; Chonnam National University Medical School; Gwangju Korea

6. Department of Internal Medicine; Catholic University of Daegu School of Medicine; Daegu Korea

7. Department of Internal Medicine; Hanyang University Guri Hospital; Guri Korea

8. Department of Internal Medicine; Kyungpook National University Hospital; Daegu Korea

9. Department of Internal Medicine; Yonsei University College of Medicine; Seoul Korea

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.27723/fullpdf

Reference25 articles.

1. EASL clinical practice guidelines: management of chronic hepatitis B virus infection;J Hepatol,2012

2. Hepatitis B virus-related cirrhosis: natural history and treatment;Chu;Semin Liver Dis,2006

3. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver;Jongh;Gastroenterology,1992

4. Occurrence of hepatocellular carcinoma and decompensation in western European patients with cirrhosis type B. The EUROHEP Study Group on Hepatitis B Virus and Cirrhosis;Fattovich;Hepatology,1995

5. Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy;Peng;J Hepatol,2012

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recompensation after TIPS reduces the incidence of hepatocellular carcinoma and increases survival in patients with cirrhosis;Liver International;2024-09-02

2. Durability and on-treatment predictors of recompensation in entecavir-treated patients with hepatitis B and decompensated cirrhosis;JHEP Reports;2024-07

3. Advancing hepatic recompensation: Baveno VII criteria and therapeutic innovations in liver cirrhosis management;World Journal of Gastroenterology;2024-06-21

4. Silymarin Synergizes with Antiviral Therapy in Hepatitis B Virus-Related Liver Cirrhosis: A Propensity Score Matching Multi-Institutional Study;International Journal of Molecular Sciences;2024-03-07

5. Managing HBV and HCV Infection Pre- and Post-liver Transplant;Journal of Clinical and Experimental Hepatology;2024-03